½ÃÀ庸°í¼­
»óǰÄÚµå
1705940

¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀå : Á¦Ç° À¯Çüº°, Ä¡·áº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®, 2025-2032³â

Elastomeric Infusion Pumps Market, by Product Type, by Treatment, by End User, and by Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ¼¼°è ½ÃÀåÀº 2025³â¿¡ 12¾ï 5,780¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 23¾ï 5,990¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 9.4%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 12¾ï 5,780¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020³âºÎÅÍ 2024³â±îÁö ¿¹Ãø ±â°£ 2025³âºÎÅÍ 2032³â±îÁö
¿¹Ãø ±â°£ : 2025-2032³â CAGR 9.40 2032³â °¡Ä¡ ¿¹Ãø 23¾ï 5,990¸¸ ´Þ·¯
±×¸². ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
Elastomeric Infusion Pumps Market-IMG1

¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ´Â ÁøÅëÁ¦, È­Çпä¹ýÁ¦, ±¹¼Ò ¸¶ÃëÁ¦, Ç×»ýÁ¦ µîÀÇ ÁÖÀÔ¿¡ »ç¿ëµÇ´Â ºñÀüÀÚ½Ä ¾àǰ ÆßÇÁÀ̸ç, dz¼± ÆßÇÁ¶ó°íµµ ÇÕ´Ï´Ù. ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ´Â ¾à¹° ÁÖÀÔ¿¡ »ç¿ëµÇ´Â ÀÏȸ¿ë ÀÇ·á±â±âÀÔ´Ï´Ù. ÁÖÀÔ °úÁ¤Àº ÆßÇÁ ³»¿¡ Á¸ÀçÇÏ´Â ¿¤¶ó½ºÅä¸Ó Ãþ¿¡ ¹ß»ýÇÏ´Â ¾ÈÁ¤µÈ ¾Ð·ÂÀÇ µµ¿òÀ¸·Î ¼öÇàµÇ¸ç, ÀÌ ¾Ð·ÂÀº ¿¤¶ó½ºÅä¸Ó Àú¼öÁö¿¡ ¹èÄ¡µÈ À¯·® Á¦Çѱ⸦ ÅëÇØ Á¦¾îµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

¾Ï°ú °°Àº ¸¸¼ºÁúȯÀÇ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, ¼¼°èº¸°Ç±â±¸(WHO)°¡ 2022³â 2¿ù 3ÀÏ ¹ßÇ¥ÇÑ ÆÑÆ®½ÃÆ®¿¡ µû¸£¸é, 2020³â¿¡´Â ¾à 1,000¸¸ ¸í, Áï »ç¸ÁÀÚ 6¸í Áß 1¸íÀÌ ¾ÏÀ¸·Î »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, Àü ¼¼°è »ç¸Á ¿øÀÎ Áß 1À§°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯¹æ¾Ï, Æó¾Ï, ´ëÀå¾Ï, Á÷Àå¾Ï, Àü¸³¼±¾ÏÀÌ °¡Àå ¸¹½À´Ï´Ù. ¶ÇÇÑ WHO¿¡ µû¸£¸é ¸Å³â ¾à 40¸¸ ¸íÀÇ ¾î¸°À̰¡ ¾Ï¿¡ °É¸°´Ù°í ÇÕ´Ï´Ù. ÀÌ¿Í °°ÀÌ ¾ÏÀÇ È®»êÀ¸·Î ÀÎÇØ ¼¼°è ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ´Â ÀüÀÚ½Ä ÆßÇÁ¿¡ ºñÇØ Àú·ÅÇÏ°í ºÎÀÛ¿ëÀÌ Àû±â ¶§¹®¿¡ ¿Ü·¡ È­Çпä¹ý ÁÖÀÔ ¼¾ÅÍ¿¡¼­ Á¡Á¡ ´õ ¸¹ÀÌ Ã¤Åõǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ´Â ÀÛµ¿¿¡ Àü±â°¡ ÇÊ¿äÇÏÁö ¾Ê±â ¶§¹®¿¡ ȯÀÚ¿¡°Ô ¾à¹°ÀÌ ÀÚÀ¯·Ó°Ô È带 À§ÇèÀÌ ¾ø½À´Ï´Ù. ÀÌ·¯ÇÑ ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁÀÇ Àü±â ÆßÇÁ¿¡ ´ëÇÑ ÀåÁ¡Àº ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
  • ¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ÆÄ¾ÇÇϰí ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ÀÎ½Ä Á¦°í Ȱµ¿
  • PEST ºÐ¼®
  • ¿ªÇÐ

Á¦4Àå ¼¼°èÀÇ ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • ¼ö¿ä¿Í °ø±Þ¿¡ ´ëÇÑ ¿µÇâ
  • COVID-19ÀÇ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â

  • °¡º¯ À¯·® ¿¤¶ó½ºÅä¸Ó ÆßÇÁ
  • »ó¿ë À¯·® ¿¤¶ó½ºÅä¸Ó ÆßÇÁ

Á¦6Àå ¼¼°èÀÇ ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀå, Ä¡·áº°, 2020-2032³â

  • ÅëÁõ °ü¸®
  • Ç×»ýÁ¦/Ç×¹ÙÀÌ·¯½ºÁ¦
  • È­Çпä¹ý
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Ŭ¸®´Ð
  • ÀçÅà Äɾî ȯ°æ
  • º´¿ø
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀå, Áö¿ªº°, 2020-2032³â

  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • B. Braun Melsungen AG
  • Fresenius Kabi
  • Leventon, S.A.U
  • Ambu A/S
  • Baxter International Inc.
  • Halyard Health
  • Nipro Corporation

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ»çÇ×

  • ±âȸ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • Coherent Opportunity Map

Á¦11Àå ¼½¼Ç

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
ksm 25.05.27

Global Elastomeric Infusion Pumps Market is estimated to be valued at USD 1,257.8 Mn in 2025 and is expected to reach USD 2,359. Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1,257.8 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.40% 2032 Value Projection: USD 2,359. Mn
Figure. Elastomeric Infusion Pumps Market Share (%), By Region 2025
Elastomeric Infusion Pumps Market - IMG1

Elastomeric infusion pumps are non-electronic medication pumps also called as balloon pumps which are used for infusion of analgesics, chemotherapy drugs, local anesthetics, antibiotics and other type of medications. Elastomeric infusion pumps are single use medical devices used for drug infusion. The process of infusion is carried out with the help of consistent pressure created in the elastomeric layer present in the pump which is controlled with the help of flow restrictors located in the elastomeric reservoir.

Market Dynamics

Increase in the prevalence of chronic diseases like cancer is expected to propel growth of market. For instance, according to factsheet published by World Health Organization (WHO) on 3 February, 2022, nearly 10 million deaths, or nearly one in six deaths were caused by cancer in 2020, making it the leading cause of death globally. Breast, lung, colon, rectum, and prostate cancers are the most prevalent types of cancer. In addition, according to WHO, each year, approximately 400,000 children develop cancer. Thus due to prevalence of cancer the global elastomeric infusion pumps market is expected grow over the forecast period.

Moreover, elastomeric infusion pumps are cheaper and have fewer adverse effects compared to electronic pumps, which increases their adoption in ambulatory chemotherapy infusion centers. Moreover, as elastomeric infusion pumps do not require electricity to operate, the risk for free flow of medication to patients is eliminated. Such advantages of elastomeric infusion pumps over their electric counterparts is also expected to boost growth of market.

Key features of the study:

  • This report provides in-depth analysis of the global elastomeric infusion pumps market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global elastomeric infusion pumps market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include B. Braun Melsungen AG, Fresenius Kabi, Leventon, S.A.U, Ambu A/S, Baxter International Inc., Halyard Health, and Nipro Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global elastomeric infusion pumps market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global elastomeric infusion pumps market

Detailed Segmentation:

  • Global Elastomeric Infusion Pumps Market, By Product Type
    • Variable Rate Elastomeric Pumps
    • Continuous Rate Elastomeric Pumps
  • Global Elastomeric Infusion Pumps Market, By Treatment
    • Pain management
    • Antibiotic/Antiviral
    • Chemotherapy
    • Others
  • Global Elastomeric Infusion Pumps Market, By End User
    • Ambulatory Surgical Centers
    • Clinics
    • Home Care Settings
    • Hospitals
    • Others
  • Global Elastomeric Infusion Pumps Market, By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • B. Braun Melsungen AG
    • Fresenius Kabi
    • Leventon, S.A.U
    • Ambu A/S
    • Baxter International Inc.
    • Halyard Health
    • Nipro Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Treatment
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Awareness Initiatives
  • PEST Analysis
  • Epidemiology

4. Global Elastomeric Infusion Pumps Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Impact on Supply and Demand
  • COVID-19 Impact on the market

5. Global Elastomeric Infusion Pumps Market, By Product Type, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Variable Rate Elastomeric Pumps
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Continuous Rate Elastomeric Pumps
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

6. Global Elastomeric Infusion Pumps Market, By Treatment, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pain management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Antibiotic/Antiviral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Chemotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

7. Global Elastomeric Infusion Pumps Market, By End User, 2020 - 2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

8. Global Elastomeric Infusion Pumps Market, By Region, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • B. Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fresenius Kabi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Leventon, S.A.U
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ambu A/S
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Halyard Health
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Nipro Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦